Back in April, Matthew Stafford was asked about why he decided to return to the Rams after testing the market. “It wasn’t something that happened on that Friday during that meeting. It’s not ...

Matthew Stafford and the Los Angeles Rams agreed to terms on a contract extension in March. The two sides have since taken the next step. The Rams finalized Stafford’s contract extension, a ...

Veteran quarterback Matthew Stafford finalized his new two-year deal with the Los Angeles Rams, according to NFL Network's Ian Rapoport. The contract can pay Stafford up to $84 million and ...

Aug 19, 2021; Thousand Oaks, CA, USA; Los Angeles Rams quarterback Matthew Stafford (9) looks on during a joint practice against the Las Vegas Raiders. Mandatory Credit: Kirby Lee-USA TODAY Sports ...

Matthew Gray Gubler fans will have to wait longer for Criminal Minds star’s return to CBS. His new comedic drama procedural Einstein, originally picked up to series last week for the 2025-26 ...

Matthew Gray Gubler’s CBS comeback will have to wait a year. The actor’s new drama series “Einstein” will be held until the 2026-27 season after landing a series order at the broadcast ...

Regeneron has leveraged its monoclonal antibody research and development platform to become one of the few biotechs to emerge as a profitable commercial operation and establish a narrow moat.

The Green Bay Packers selected Texas football wide receiver Matthew Golden with the No. 23 pick in the 2025 NFL Draft. Golden was the fourth receiver off the board, finalizing a rapid rise that ...

Her work has previously appeared in The Hollywood Reporter. Michael Loccisano/Getty; Michael Tullberg/Getty Matthew Rhys isn't above getting starstruck. While filming the new BritBox murder ...

Shares of biotech company Regeneron (NASDAQ:REGN) fell 9.6% in the morning session after the company reported weak first-quarter 2025 results. Its revenue missed significantly, and its EPS fell ...

Regeneron Pharmaceuticals (REGN) reported its first-quarter 2025 earnings, revealing a miss on both earnings and revenue expectations. The company posted earnings per share (EPS) of $8.22, falling ...

Shares of Regeneron Pharmaceuticals (NASDAQ:REGN) came under pressure in the premarket on Tuesday after the company’s Q1 2025 financials fell short of Street forecasts amid disappointing sales ...